Bolt Biotherapeutics (BOLT) Share Buybacks: History & Chart

Bolt Biotherapeutics, Inc.(BOLT)

Biotechnology · Redwood City, CA

$3.54+0.04 (+1.17%)

Delayed quote: Oct 6, 2026, 12:06 PM EDT

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indications such as colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody designed to reprogram crucial immune cells within the tumor microenvironment by interacting with macrophage cell-surface receptors. Bolt is also pursuing a programmed cell death-ligand 1 (PD-L1) initiative aimed at addressing tumors that prove resistant to existing immune checkpoint blockades. Incorporated in 2015 under its previous name, Bolt Therapeutics, Inc., before officially becoming Bolt Biotherapeutics, Inc. in July of the same year, the company maintains its corporate headquarters in Redwood City, California.

Redwood City, CA

23 employees

www.boltbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William Quinn

View full financials

Share Buybacks

The latest quarterly buybacks is $0. Share buybacks (stock repurchases) represent cash spent by the company to buy back its own shares in the open market, reducing shares outstanding and returning capital to shareholders.

Q2 FY2026 (2026-06-30).

Dividends|Stock-Based Comp|EPS|Free Cash Flow|Cash Flow

Buybacks

BOLT Buybacks

$0.00

Reported quarterly buybacks; no daily interpolation. Q2 FY2026 (2026-06-30): $0.00.

Current Buybacks

Q2 FY2026 · 2026-06-30

QoQ Growth

N/A

Historical Data

Quarters of data available

Quarterly Buybacks History

Period	Buybacks	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	$0	N/A	N/A
Q1 FY2026Period end 2026-03-31	$0	N/A	N/A
Q4 FY2025Period end 2025-12-31	$0	N/A	N/A
Q3 FY2025Period end 2025-09-30	$0	N/A	N/A
Q2 FY2025Period end 2025-06-30	$0	N/A	N/A
Q1 FY2025Period end 2025-03-31	$0	N/A	N/A
Q4 FY2024Period end 2024-12-31	$0	N/A	N/A
Q3 FY2024Period end 2024-09-30	$0	N/A	N/A
Q2 FY2024Period end 2024-06-30	$0	N/A	N/A
Q1 FY2024Period end 2024-03-31	$0	N/A	N/A
Q4 FY2023Period end 2023-12-31	$0	N/A	N/A
Q3 FY2023Period end 2023-09-30	$0	N/A	N/A
Q2 FY2023Period end 2023-06-30	$0	N/A	N/A
Q1 FY2023Period end 2023-03-31	$0	N/A	N/A
Q4 FY2022Period end 2022-12-31	$0	N/A	N/A
Q3 FY2022Period end 2022-09-30	$0	N/A	N/A
Q2 FY2022Period end 2022-06-30	$0	N/A	N/A
Q1 FY2022Period end 2022-03-31	$0	N/A	N/A
Q4 FY2021Period end 2021-12-31	$0	N/A	N/A
Q3 FY2021Period end 2021-09-30	$0	N/A	N/A
Q2 FY2021Period end 2021-06-30	$0	N/A	N/A
Q1 FY2021Period end 2021-03-31	$0	N/A	N/A
Q4 FY2020Period end 2020-12-31	$0	N/A	N/A
Q3 FY2020Period end 2020-09-30	$0	N/A	N/A
Q2 FY2020Period end 2020-06-30	$0	N/A	N/A
Q1 FY2020Period end 2020-03-31	$0	N/A	N/A
Q4 FY2019Period end 2019-12-31	$0	N/A	N/A
Q3 FY2019Period end 2019-09-30	$0	N/A	N/A
Q2 FY2019Period end 2019-06-30	$0	N/A	N/A
Q1 FY2019Period end 2019-03-31	$0	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.

Data as of June 30, 2026